Sylvie Lehmann

Structural Basis for the Exceptional in vivo Efficacy of Bisphosphonate Drugs

Jean‐Michel Rondeau, Francis Bitsch, E. Bourgier et al. · ChemMedChem · 2006 · 223 citations

Life Sciences, Biochemistry, Pharmacology +17

Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy

Frédéric Morvan, Jean‐Michel Rondeau, Giulia Minetti et al. · Proceedings of the National Academy of Sciences · 2017 · 138 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery

Wolfgang Jahnke, Jean‐Michel Rondeau, Simona Cotesta et al. · Nature Chemical Biology · 2010 · 125 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties

A. Goepfert, Sylvie Lehmann, Emmanuelle Wirth et al. · Scientific Reports · 2017 · 99 citations · Full text

Life Sciences, Immunology, Autoimmunity +12

Structural Analysis Reveals that the Cytokine IL-17F Forms a Homodimeric Complex with Receptor IL-17RC to Drive IL-17RA-Independent Signaling

A. Goepfert, Sylvie Lehmann, Jutta Blank et al. · Immunity · 2020 · 76 citations · Full text

Life Sciences, Immunology, Molecular Biology +12